TDRD3 and breast cancer: Recent in vitro studies on the transcriptional co-activator TDRD3—a Tudor-domain protein that binds to H4R3me2a—show that this protein binds to the TSS regions of certain genes in human breast cancer cells (46); however, no significant enrichment was detected on the non-methylated alleles of human ICRs.